Currently, there are no easy-to-use, accurate, non-contact, and painless pre-diagnostic methods to know the risk of chronic diseases. Existing questioner-based Risk assessment tools for identifying individuals at-risk of developing Type 2 Diabetes and Hypertension are indirect methods and week indicators. Blood tests for hyperglycemia offer a diagnosis but do not provide the risk of developing the disease. General preventive healthcare solutions provide tests of one disease per device only, necessitating multiple tests. Due to this, the user is not opting for pre-diagnostic tests resulting in delayed care. Also, non-compliance with regular assessment of chronic diseases often leads to patients reaching hospitals late with increased disease severity.
Our solutions encourage users to undergo regular health check-ups. We, at Aarca Research, have developed a novel technology using artificial intelligence for early detection and risk assessment of chronic diseases including Type 2 diabetes, hypertension, Dyslipidemia. We use an FDA approved thermal camera to take biomarker information of the users and our first-of-its-kind proprietary software uses computer vision to evaluate the comorbidity risk profile of an individual. We have filed for seven patents as on date for our technology.
Advantages of our technology:
Our vision is to excel in pre-diagnosis using technology to help everyone live healthier. Explore our solutions here.